The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity

C. Shu (Taipei, Taiwan), P. Wang (BNew Taipei City, Taiwan), M. Wu (Taipei, Taiwan)

Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Shu (Taipei, Taiwan), P. Wang (BNew Taipei City, Taiwan), M. Wu (Taipei, Taiwan). The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity. 4208

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
Source: Annual Congress 2011 - T-cell subsets
Year: 2011

Evidence for cell mediated immune dysfunction in the COPD lung: The role of cytotoxic CD4+ T cells
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015

The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

How do antigen presenting cells see pathogens and cells?
Source: Annual Congress 2006 - Targeting innate immunity in respiratory diseases
Year: 2006


Regulator and effector T lymphocytes in late stages of non small cell lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012

Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


T cell exhaustion marker expression in the human lung in health and COPD in response to influenza infection
Source: Annual Congress 2013 –COPD and infections
Year: 2013


The profile of dendritic cell and T cell response is related to the viral trigger in children with severe asthma exacerbation
Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma
Year: 2012



Role of regulatory T-cells (Tregs) in bacterial infection-induced lung fibrosis exacerbation in mice
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018

The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006

Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells
Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma
Year: 2012


Expanded lung T-bet+RORyT+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotype
Source: Eur Respir J 2016; 48: 484-494
Year: 2016



Accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006


Our experience of T cell assays in the diagnosis of MTB disease and latent infection
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007


T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 344s
Year: 2006

Cytotoxic T cell antigen 4 and the status of T cell activation in lung cancer: local vs. systemic immune response.
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017



Diminished peripheral T cell activity in sarcoidosis associates with progressive disease.
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018



The attenuation of cytokine response might be correlated with gut dysbiosis in nontuberculous mycobacteria lung disease
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019

The innate immune function of airway epithelial cells in inflammatory lung disease
Source: Eur Respir J 2015; 45: 1150-1162
Year: 2015